Purchase Order 75N95020P00260
Award Date 6/29/20
Potential Completion Date 7/31/20
Potential Value $27K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Frederick, MD 21701, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm-fixed-price contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services (HHS) National Institutes of Health (NIH), to Lifeline Cell Technology, LLC, a small business manufacturer of goods. The $15,100.80 contract is for the provision of pulmonary epithelial cultures. The contract was set aside for small businesses and has a completion date of September 28, 2018. Lifeline Cell Technology, LLC...
- This federal contract award is for $142,563.00 to Biosurfaces Inc., a for-profit vendor that provides medical and laboratory supplies, equipment, and services to the Department of Health and Human Services (HHS), primarily the National Institutes of Health (NIH). The award is for the provision of expandable lung alveolar epithelial cells in support of coronavirus (COVID-19) research conducted by the NIH's National Center for Advancing Translational Sciences. This non-competitive acquisition...
- This is a sole-source contract awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Mattek Corp, a for-profit manufacturer of human tissue models. The $225,126 Firm Fixed Price contract is for the delivery of human alveolar, tracheobronchial, and gut tissue samples to support NCATS' efforts to rapidly characterize SARS-CoV-2 variants and test antiviral therapies. The contract does not have a set-aside designation, as...
- This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (part of the National Institutes of Health) to Mattek Corporation, a small business manufacturer of human tissue models. The $98,259.02 contract is for the delivery of alveolar and tracheobronchial tissues in a ready-made format to support COVID-19 drug testing. The original solicitation was a total small business set-aside with a quick turnaround of 35 days for delivery to the NIH in...
- This firm fixed price purchase order for $949,800 was awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to Mattek Corporation. The contract calls for the delivery of 600 EpiAirway 3D respiratory epithelial non-human primate microtissues and 600 EpiAlveolar 3D small airway non-human primate microtissues to support SARS-CoV-2 variant and therapeutics testing being conducted by the National Institute on Drug...
- This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS) National Institutes of Health (NIH), to Mattek Corp, a foreign-owned for-profit manufacturer of human tissue models and assay kits. The $12,137 firm fixed-price purchase order is for the development of an NHBE (normal human bronchial epithelial) cell line using CRISPR/Cas or RNA interference (RNAi) technology. The contract has a small...
- This firm fixed-price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Mattek Corporation, a foreign-owned, for-profit manufacturer of human tissue models. The $187,370.03 award is for providing human alveolar and tracheobronchial tissues to support viral infection/disease modeling and antiviral discovery research for SARS-CoV-2. The original solicitation was a non-competitive,...
- This is a $24,900 firm-fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Center for Advancing Translational Sciences to 3Dnamics Inc., a biotechnology company that provides stem cell engineering technology and related services. The contract is for the differentiation of induced pluripotent stem cells (iPSCs) into hepatocyte organoids, which are three-dimensional cell cultures that model liver tissue. This work supports...
- This is a firm-fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Mimetas Operations US, CO. for 25 units of the Organoplate Graft (part number 6401-400-B), a microfluidic 3D cell culture plate used in research related to SARS-CoV-2 and COVID-19. The $29,075.00 contract was awarded on a sole-source, non-competitive basis due to...
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $29,353.50 firm-fixed-price purchase order to Stemcell Technologies Inc. under a non-competitive combined synopsis/solicitation. The contract is to provide antiviral products for neurotropic viruses of pandemic potential, as described in the attached purchase description, to support research efforts. Performance will take place in Kent, Washington, with a...
This contract was awarded by the National Center for Advancing Translational Sciences (NCATS), which is a civilian agency under the National Institutes of Health (NIH), to Lifeline Cell Technology, LLC, a subsidiary of International Stem Cell Corporation, to purchase human small airway epithelial primary cells. The cells are being acquired to develop a 3D vascularized lung model to mimic SARS-CoV-2 viral infection, in support of COVID-19 research. The contract has a firm fixed price of $26,920.84 and a completion date of July 31, 2020. No set-aside designation was used for this non-competitive, urgent acquisition.
Generated 6/26/24, 10:15 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Acquisition of human small airway epithelial primary cells | 75N95020Q00152 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Solicitation 1/1 | 6/15/20, 12:43 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.9k | 6/29/20 |